Article Text
Abstract
The 'Best of ESGO 2024' article includes a selection of the most highly rated original research presented during the 25th Annual Congress of the European Society of Gynaecologic Oncology (ESGO), held in Barcelona, Spain, March 7–10, 2024. Of 1218 asbtracts submitted, 35 studies presented during the best oral sessions, mini oral sessions, best three minute presentations session, and young investigator session were selected by the ESGO abstract committee and the authors of the European Network of Young Gynae Oncologists (ENYGO). There was a strong focus on the surgical treatment of early stage cervical cancer and the management of advanced or recurrent gynecological cancers using induction therapy, immunotherapy, and maintenance therapy. With this work, ENYGO and ESGO aim to focus the attention of clinicians, scientists, patients, and all stakeholders interested in gynecologic oncology on research advances in the field.
- Cervical Cancer
- Ovarian Cancer
- Uterine Cancer
Statistics from Altmetric.com
Footnotes
X @Joanna86992517, @housseinelhajj3, @esragbilir, @aStrojnaMD, @AngelesFite
Contributors All authors contributed to the preparation of the manuscript. Data collection and manuscript preparation: JK-B, HEH, NB, EB, TAZ, ANS, KG, MAA, VG, HE, TN, CT, and RT. Project administration and preparation of the original draft: JK-B. Supervision and critical revisions: JPS, LC, and DL.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.